PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE?

Por I. V. Zotova, D. A. Zateyshchikov
Publicado em 2016-01-01

Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice

Por I. V. Zotova, D. A. Zateyshchikov
Publicado em 2020-09-01

Powerful terahertz free electron lasers with hybrid Bragg reflectors

Por N. S. Ginzburg, A. M. Malkin, N. Yu. Peskov, A. S. Sergeev, V. Yu. Zaslavsky, I. V. Zotova
Publicado em 2011-04-01

GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION

Por I. V. Zotova, A. N. Brovkin, E. N. Fattakhova, A. N. Nikitin, V. V. Nosikov, V. A. Brazhnik, D. A. Zateyshchikov
Publicado em 2015-10-01

Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19

Por S. N. Avdeev, A. V. Bazarova, E. I. Baranova, A. M. Esayan, G. K. Zhusupova, M. N. Zamyatin, I. V. Zotova, S. L. Kasenova, S. T. Matskeplishvili, O. N. Miller, A. M. Pak, V. V. Salukhov, V. V. Tyrenko, D. R. Khasanova, N. A. Shamalov, S. N. Yanishevsky
Publicado em 2020-09-01